Page last updated: 2024-08-23

haloperidol decanoate and Dementia Praecox

haloperidol decanoate has been researched along with Dementia Praecox in 99 studies

Research

Studies (99)

Timeframe	Studies, this research(%)	All Research%
pre-1990	26 (26.26)	18.7374
1990's	36 (36.36)	18.2507
2000's	13 (13.13)	29.6817
2010's	23 (23.23)	24.3611
2020's	1 (1.01)	2.80

Authors

Authors	Studies
Apramian, A; Kajani, R; Liu, A; Ubhayakar, N; Vega, A; Xu, P	1
De Vos, C; Decuypere, F; Denee, TR; Geerts, P; Lamotte, M; Malfait, B; Mulder, CL; Sermon, J	1
Dekkers, BGJ; Eck, RJ; Ter Maaten, JC; Touw, DJ	1
Tagne Nouemssi, AB	1
Bareis, NA; McEvoy, JP; Rosenheck, RA; Stroup, TS; Swartz, MS	1
Ansolabehere, X; Guillon, P; Harmand, S	1
Den, R; Mimura, M; Sakurai, H; Suzuki, T; Tsutsumi, C; Uchida, H; Uchida, T	1
Bošković, M; Grabnar, I; Kores Plesničar, B; Terzič, T; Vovk, T	1
Bø, CN; Einarson, TR; Hemels, ME; Jensen, R; Piwko, C; Pudas, H; Vicente, C; Zilbershtein, R	1
Bialko, CS; Cassidy, KA; Fuentes-Casiano, E; Hahn, DY; Levin, J; Ramirez, LF; Sajatovic, M; Tatsuoka, C; Williams, TD	1
Haroutunian, V; Meador-Woodruff, JH; Pinner, AL	1
Buckley, PF; Byerly, M; Dominik, R; Hamer, RM; Lamberti, JS; McEvoy, JP; Ray, N; Rosenheck, RA; Stroup, TS; Swartz, MS; Wilkins, TM	1
Bošković, M; Grabnar, I; Koprivšek, J; Plesničar, BK; Vovk, T	1
Chan, CL; Guo, LT; Ng, SM; Ran, MS; Xiang, MZ	1
Haroutunian, V; Kippe, JM; Meador-Woodruff, JH; Mueller, TM	1
Caton, M; Newman, WJ; Scangos, KW	1
Byerly, MJ; Hamer, RM; Leslie, DL; Li, Y; Lin, H; McEvoy, JP; Rosenheck, RA; Sint, KJ; Stroup, TS; Swartz, MS	1
Ide, GD; Khan, AY; Ovais, M; Salaria, S	1
Citrome, L; Jaffe, A; Levine, J	1
Brahm, NC; Washington, NB	1
Covell, NH; Essock, SM; Jackson, CT; McEvoy, JP; Rojas, IA; Schooler, NR; Stroup, TS	1
Gen, K; Suzuki, H	1
Drummond, JB; Haroutunian, V; Meador-Woodruff, JH; Simmons, M	1
Bellaaj, R; Bouguerra, C; Gallali, S; Mehdi, F; Oumaya, A; Sejil, I	1
Chengappa, KN; Jeste, DV; Mamo, DC; Reddy, RR; Sweet, RA	1
Girard, F; Ikehira, H; Obata, T; Okubo, Y; Sassa, T; Suhara, T; Tanada, S	1
Eggan, SM; Hashimoto, T; Lewis, DA; Mirnics, K; Pierri, JN; Sampson, AR; Sun, Z; Volk, DW	1
Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M	1
Glick, ID; Marder, SR	1
Buschman, HP; Hariz, M; Kölling, P; Lenders, MW; Steur, EN; Vergouwen, MD	1
Adetunji, B; Basil, B; Mathews, M; Osinowo, T; Williams, A	1
McEvoy, JP	1
Ascher-Svanum, H; Faries, D; Marder, SR; Montgomery, W; Shi, L; Zhu, B	1
Kantrowitz, JT; Srihari, VH; Tek, C	1
Roncoroni, D	1
Mori, A	1
arap Mengech, HN; Wazome, EG	1
Annable, L; Boisvert, D; Bradwejn, J; Campbell, W; Chouinard, G	1
Alexandre, JY; Clerc, G; Darondel, A; Delaunay, J; Delteil, P; Leger, JM; Lemperiere, T; Malauzat, D; Raynaud, J; Ropert, R	1
Fernando, J; Jones, GG; Krishna Raju, R; Stanley, RO	1
Aerts, TJ; Gelders, YG; Heykants, JJ; Reyntigens, AJ; Woestenborghs, RJ	1
Aerts, TJ; Ash, CW; Gelders, YG; Reyntijens, AJ	1
Jaffe, E; Reider, R; Sharif, Z; Trémeau, F	1
Amico, E; Goff, DC; Hubbard, JW; Midha, KK; Sarid-Segal, O	1
Maj, M; Martino, M; Monteleone, P; Piccolo, A	1
Bertilsson, L; Dahl, ML; Farde, L; Halldin, C; Nyberg, S	1
Dencker, SJ; Giös, I; Mårtensson, E; Nordén, T; Nyberg, G; Persson, R; Roman, G; Stockman, O; Svärd, KO	1
Agenet, C; Barges-Bertocchio, MH; Levron, JC; Pupeschi, G	1
Baruah, S; Sherman, A; Waziri, R	1
Anderson, C; Ereshefsky, L; Saklad, SR; Seidel, D; Toney, G	1
Brauzer, B; Casey, DE; Davis, JM; Gierl, B; Hassan, M; Kane, JM; Marder, SR; Schooler, N	1
Cesková, E; Rysánek, R; Svestka, J	1
Zbytovský, J	1
Schellenberg, R; Schwarz, A	1
Beckmann, H; Fritze, J; Riederer, P; Wodarz, N	1
Chang, WH; Chen, LC; Chien, CP; Hu, WH; Jann, MW; Juang, DJ; Lam, YF; Lin, SK; Yang, CH	1
Chang, WH; Chen, LC; Chien, CP; Hu, WH; Jann, MW; Juang, DJ; Lam, YW; Lin, SK; Yang, CH	1
Chang, WH; Chen, LC; Jann, MW; Juang, DJ; Lane, HY; Lin, SK; Yang, CH	1
Chang, WH; Jann, MW; Lin, HN; Piao-Chien, C; Wei, FC	2
Aymard, N; Caroli, F; Stein, I; Viala, A	1
Haavisto, E; Huttunen, MO; Nyholm, R; Pitkänen, M; Raitasuo, V; Romanov, M; Tuhkanen, H	1
Levander, S; Tuninger, E	1
Dhopesh, V; Gamble, G; Maany, I; Macfadden, A	1
Albus, M; Mager, T; Oertel, WH; Scherer, J; Schwarz, J; Tatsch, K	1
Farde, L; Halldin, C; Nyberg, S	1
Freccero-Rosman, K; Levander, S; Ohlsson, T; Rosén, I; Ryding, E; Sjöholm, H; Tuninger, E	1
Conley, RR; Kelly, DL; Love, RC; Moore, DB; Sherr, JD	1
Belpaire, FM; Berlo, JA; De Schepper, N; Pan, L; Rosseel, MT; Vander Stichele, R	1
David, A; Quraishi, S	1
Averill, P; Hays, JR; Varner, RV; Wagner, AL	1
Brauzer, B; Casey, D; Conley, R; Davis, JM; Kane, JM; Marder, S; Mintz, J; Schooler, N	1
Haufe, C; Knorr, W; Schellenberg, R; Schwarz, A	1
Koskinen, T; Mølbjerg, C; Nerdrum, T; Pedersen, V; Thelander, S; Wistedt, B	1
Youssef, HA	1
Eklund, K; Forsman, A	1
Edwards, JG; Fukushima, Y; Goldie, A; Kaneko, S; Sato, T	1
Cookson, JC	1
Altamura, CA; Colacurcio, F; De Novellis, F; Mauri, MC; Moro, AR	1
Kalugina, LI; Kopeĭko, GI; Kravchenko, NE; Mirzoian, MG; Ushakov, IuV	1
McCreadie, RG; Whitehead, A; Wiles, DH	1
Annable, L; Campbell, W; Chouinard, G	1
Alda, M; Dufkova, D; Kristofikova, Z; Pavlovsky, P	1
Zapletálek, M; Zbytovský, J	1
Nasser, J; Thomas, B	1
Knudsen, P	1
Kane, JM	1
Kissling, W; Möller, HJ	1
Rueda-Vasquez, E	1
McCreadie, RG; McKane, JP; Robinson, AD; Stirling, GS; Wiles, DH	1
Achim, A; Lizondo, E; Nayak, R; Schwartz, G; Suranyi-Cadotte, B; Thavundayil, JX; Vasavan Nair, NP	1
Cookson, JC; Gribbon, D; Kennedy, NM	1
Wistedt, B	1
Gelders, YG	1
Leff, JP; Tress, KH	1
Eberhard, G; Hellbom, E	1
Kissling, W; Krueger, R; Möller, HJ; Trenk, D; Walter, K; Wittmann, B	1
Agnoli, A; Casacchia, M; Falaschi, P; Meco, G; Petrini, P; Rocco, A; Rosa, M	1

Reviews

5 review(s) available for haloperidol decanoate and Dementia Praecox

Article	Year
Depot antipsychotics: Where do we stand? Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2016, Volume: 28, Issue:4 Topics: Antipsychotic Agents; Haloperidol; Hospitalization; Humans; Medication Adherence; Paliperidone Palmitate; Schizophrenia	2016
Risks versus benefits of different types of long-acting injectable antipsychotics. The Journal of clinical psychiatry, 2006, Volume: 67 Suppl 5 Topics: Administration, Oral; Antipsychotic Agents; Fluphenazine; Haloperidol; Health Care Costs; Humans; Injections, Intramuscular; Microspheres; Quality of Life; Risk Assessment; Risperidone; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Treatment Refusal	2006
[Recent advances in clinical psychopharmacology]. Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology, 1984, Volume: 4, Issue:3 Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benzamides; Carbamazepine; Dyskinesia, Drug-Induced; Haloperidol; Humans; Kinetics; Lithium; Psychopharmacology; Schizophrenia	1984
Dose response of prophylactic antipsychotics. The Journal of clinical psychiatry, 1993, Volume: 54 Suppl Topics: Administration, Oral; Aftercare; Antipsychotic Agents; Combined Modality Therapy; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Humans; Patient Compliance; Psychotherapy; Recurrence; Schizophrenia; Schizophrenic Psychology	1993
Depot haloperidol decanoate for schizophrenia. The Cochrane database of systematic reviews, 2000, Issue:2 Topics: Antipsychotic Agents; Delayed-Action Preparations; Haloperidol; Humans; Schizophrenia	2000

Trials

32 trial(s) available for haloperidol decanoate and Dementia Praecox

Article	Year
Heterogeneity of Treatment Effects of Long-Acting Injectable Antipsychotic Medications. The Journal of clinical psychiatry, 2018, 11-27, Volume: 80, Issue:1 Topics: Adolescent; Adult; Affective Disorders, Psychotic; Age Factors; Aged; Antipsychotic Agents; Delayed-Action Preparations; Female; Haloperidol; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Paliperidone Palmitate; Progression-Free Survival; Schizophrenia; Treatment Failure; Young Adult	2018
Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder. The Journal of clinical psychiatry, 2013, Volume: 74, Issue:12 Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Delayed-Action Preparations; Female; Haloperidol; Hospitalization; Humans; Ill-Housed Persons; Injections, Intramuscular; Male; Medication Adherence; Prospective Studies; Psychiatric Status Rating Scales; Psychological Techniques; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; United States	2013
Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial. JAMA, 2014, May-21, Volume: 311, Issue:19 Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Double-Blind Method; Female; Haloperidol; Hospitalization; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Schizophrenia; Treatment Failure; Treatment Outcome; Weight Gain	2014
Vitamin E and essential polyunsaturated fatty acids supplementation in schizophrenia patients treated with haloperidol. Nutritional neuroscience, 2016, Volume: 19, Issue:4 Topics: Administration, Oral; Adult; Antioxidants; Antipsychotic Agents; Biomarkers; Combined Modality Therapy; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Dietary Supplements; Double-Blind Method; Fatty Acids, Essential; Fatty Acids, Omega-3; Haloperidol; Humans; Male; Middle Aged; Oleic Acid; Oxidative Stress; Pilot Projects; Psychiatric Status Rating Scales; Schizophrenia; Vitamin E	2016
The effectiveness of psychoeducational family intervention for patients with schizophrenia in a 14-year follow-up study in a Chinese rural area. Psychological medicine, 2015, Volume: 45, Issue:10 Topics: Adult; Aged; Analysis of Variance; Antipsychotic Agents; China; Family; Female; Follow-Up Studies; Haloperidol; Humans; Interviews as Topic; Male; Middle Aged; Patient Acceptance of Health Care; Patient Education as Topic; Rural Population; Schizophrenia; Schizophrenic Psychology	2015
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia. Psychiatric services (Washington, D.C.), 2016, 10-01, Volume: 67, Issue:10 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cost-Benefit Analysis; Delayed-Action Preparations; Double-Blind Method; Female; Haloperidol; Humans; Injections; Male; Middle Aged; Outcome Assessment, Health Care; Paliperidone Palmitate; Patient Acceptance of Health Care; Psychotic Disorders; Quality-Adjusted Life Years; Schizophrenia; United States; Young Adult	2016
Effectiveness of switching from long-acting injectable fluphenazine or haloperidol decanoate to long-acting injectable risperidone microspheres: an open-label, randomized controlled trial. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:5 Topics: Antipsychotic Agents; Connecticut; Delayed-Action Preparations; Drug Substitution; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Hyperprolactinemia; Injections; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Microspheres; Middle Aged; Patient Compliance; Proportional Hazards Models; Risperidone; Schizophrenia; Weight Gain	2012
The influence of switching from haloperidol decanoate depot to risperidone long-acting injection on the clinical symptoms and cognitive function in schizophrenia. Human psychopharmacology, 2012, Volume: 27, Issue:5 Topics: Adult; Aged; Antipsychotic Agents; Cognition Disorders; Delayed-Action Preparations; Diagnosis, Computer-Assisted; Executive Function; Female; Haloperidol; Humans; Injections; Male; Memory; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Time Factors; Treatment Outcome	2012
19F-magnetic resonance spectroscopy and chemical shift imaging for schizophrenic patients using haloperidol decanoate. Psychiatry and clinical neurosciences, 2002, Volume: 56, Issue:6 Topics: Adult; Antipsychotic Agents; Female; Fluorine; Haloperidol; Humans; Injections, Intramuscular; Isotopes; Magnetic Resonance Spectroscopy; Male; Middle Aged; Schizophrenia	2002
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics. International clinical psychopharmacology, 2004, Volume: 19, Issue:4 Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia	2004
Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:5 Topics: Administration, Oral; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzothiazepines; Female; Haloperidol; Humans; Incidence; Injections, Intramuscular; Long-Term Care; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Survival Analysis; Treatment Outcome	2005
A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia. Psychopharmacology bulletin, 1984,Winter, Volume: 20, Issue:1 Topics: Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Schizophrenia	1984
A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia. Psychopharmacology, 1995, Volume: 117, Issue:4 Topics: Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Fluphenazine; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	1995
A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients. Psychopharmacology, 1994, Volume: 114, Issue:1 Topics: Adult; Antipsychotic Agents; Chromatography, High Pressure Liquid; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Perphenazine; Prolactin; Schizophrenia; Schizophrenic Psychology; Spectrophotometry, Ultraviolet	1994
A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy. The Journal of clinical psychiatry, 1996, Volume: 57, Issue:7 Topics: Administration, Oral; Adult; Antipsychotic Agents; Chronic Disease; Drug Administration Schedule; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Patient Compliance; Prospective Studies; Recurrence; Schizophrenia; Treatment Outcome	1996
Pharmacoclinical correlations in schizophrenic patients treated with haloperidol decanoate: clinical evaluations, concentrations of plasma and red blood cell haloperidol and its reduced metabolite, and plasma homovanillic acid. Progress in neuro-psychopharmacology & biological psychiatry, 1995, Volume: 19, Issue:7 Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Erythrocytes; Female; Haloperidol; Homovanillic Acid; Humans; Kinetics; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Time Factors	1995
Low- and standard-dose depot haloperidol combined with targeted oral neuroleptics. Psychiatric services (Washington, D.C.), 1996, Volume: 47, Issue:1 Topics: Administration, Oral; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Neurologic Examination; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	1996
D2-dopamine-receptor occupancy during treatment with haloperidol decanoate. European archives of psychiatry and clinical neuroscience, 1997, Volume: 247, Issue:2 Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Middle Aged; Receptors, Dopamine D2; Schizophrenia	1997
A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia. The American journal of psychiatry, 2002, Volume: 159, Issue:4 Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	2002
Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double-blind multicentre study. Acta psychiatrica Scandinavica, 1991, Volume: 84, Issue:1 Topics: Adult; Antipsychotic Agents; Chronic Disease; Clopenthixol; Double-Blind Method; Female; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sex Factors	1991
Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo. Clinical neuropharmacology, 1991, Volume: 14 Suppl 2 Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Radioimmunoassay; Recurrence; Schizophrenia	1991
Side effects during long-term treatment with depot antipsychotic medication. Clinical neuropharmacology, 1991, Volume: 14 Suppl 2 Topics: Akathisia, Drug-Induced; Delayed-Action Preparations; Double-Blind Method; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Parkinson Disease, Secondary; Psychomotor Agitation; Recurrence; Schizophrenia	1991
[Clinical and economic approach to evaluation of the effectiveness of moditen-depot and haloperidol decanoate in the maintenance therapy of attack-like schizophrenia]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1990, Volume: 90, Issue:7 Topics: Antipsychotic Agents; Cost-Benefit Analysis; Fluphenazine; Haloperidol; Humans; Remission Induction; Schizophrenia	1990
Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia. Psychopharmacology, 1990, Volume: 101, Issue:2 Topics: Adult; Aged; Biological Availability; Double-Blind Method; Female; Fluphenazine; Half-Life; Haloperidol; Humans; Male; Middle Aged; Prolactin; Radioimmunoassay; Schizophrenia	1990
A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia. Journal of clinical psychopharmacology, 1989, Volume: 9, Issue:4 Topics: Adolescent; Adult; Aged; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	1989
Dosage strategies with long-acting injectable neuroleptics, including haloperidol decanoate. Journal of clinical psychopharmacology, 1986, Volume: 6, Issue:1 Suppl Topics: Antipsychotic Agents; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administration Schedule; Haloperidol; Humans; Injections; Schizophrenia	1986
Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients. The British journal of psychiatry : the journal of mental science, 1987, Volume: 151 Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Random Allocation; Schizophrenia	1987
A clinical trial comparing intramuscular haloperidol decanoate and oral haloperidol in chronic schizophrenic patients: efficacy, safety, and dosage equivalence. Journal of clinical psychopharmacology, 1986, Volume: 6, Issue:1 Suppl Topics: Administration, Oral; Adult; Chronic Disease; Clinical Trials as Topic; Female; Haloperidol; Humans; Injections, Intramuscular; Kinetics; Male; Middle Aged; Schizophrenia	1986
Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate. International clinical psychopharmacology, 1986, Volume: 1 Suppl 1 Topics: Adult; Body Weight; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prolactin; Schizophrenia	1986
A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients. International clinical psychopharmacology, 1986, Volume: 1 Suppl 1 Topics: Adult; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Schizophrenia	1986
Haloperidol decanoate and flupenthixol decanoate in schizophrenia. A long-term double-blind cross-over comparison. Acta psychiatrica Scandinavica, 1986, Volume: 74, Issue:3 Topics: Adult; Double-Blind Method; Female; Flupenthixol; Haloperidol; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes	1986
Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention. Pharmacopsychiatry, 1985, Volume: 18, Issue:3 Topics: Adult; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Schizophrenia	1985

Other Studies

62 other study(ies) available for haloperidol decanoate and Dementia Praecox

Article	Year
Neuroleptic malignant syndrome in a COVID-19 patient. Brain, behavior, and immunity, 2020, Volume: 88 Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coronavirus Infections; COVID-19; Dantrolene; Dopamine Agonists; Enzyme Inhibitors; Haloperidol; Humans; Hydroxychloroquine; Intensive Care Units; Leukocytosis; Lymphopenia; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Pandemics; Pneumonia, Viral; Renal Dialysis; Respiration, Artificial; Rhabdomyolysis; SARS-CoV-2; Schizophrenia	2020
Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study. PloS one, 2017, Volume: 12, Issue:6 Topics: Adult; Antipsychotic Agents; Belgium; Benzodiazepines; Delayed-Action Preparations; Drug Administration Schedule; Female; Haloperidol; Humans; Medication Adherence; Netherlands; Olanzapine; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome	2017
An acute oral intoxication with haloperidol decanoate. The American journal of emergency medicine, 2017, Volume: 35, Issue:9 Topics: Administration, Oral; Antipsychotic Agents; Arrhythmias, Cardiac; Charcoal; Electrocardiography; Female; Haloperidol; Humans; Laxatives; Male; Schizophrenia; Young Adult	2017
Risperidone-associated sinus tachycardia potentiated by paliperidone palmitate in a patient with no prior cardiovascular disease: role of risperidone-related autonomic instability. BMJ case reports, 2018, Apr-21, Volume: 2018 Topics: Antipsychotic Agents; Autonomic Nervous System; Cardiovascular Diseases; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haloperidol; Humans; Male; Paliperidone Palmitate; Risperidone; Schizophrenia; Tachycardia, Sinus; Treatment Outcome; Young Adult	2018
Real-life persistence of long-acting injectable antipsychotics in schizophrenic patients: A retrospective observational study in France . International journal of clinical pharmacology and therapeutics, 2019, Volume: 57, Issue:9 Topics: Antipsychotic Agents; Delayed-Action Preparations; France; Haloperidol; Humans; Injections; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia	2019
Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review. International clinical psychopharmacology, 2013, Volume: 28, Issue:5 Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Drug Combinations; Female; Fluphenazine; Haloperidol; Humans; International Classification of Diseases; Longitudinal Studies; Maintenance Chemotherapy; Male; Medical Records; Medication Adherence; Middle Aged; Retrospective Studies; Schizophrenia; Secondary Prevention; Treatment Outcome	2013
Oxidative stress in schizophrenia patients treated with long-acting haloperidol decanoate. Psychiatry research, 2013, Dec-30, Volume: 210, Issue:3 Topics: Adult; Antioxidants; Antipsychotic Agents; Basal Ganglia Diseases; Catalase; Female; Glutathione; Glutathione Peroxidase; Haloperidol; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Psychopathology; Schizophrenia; Severity of Illness Index; Superoxide Dismutase	2013
Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden. Nordic journal of psychiatry, 2014, Volume: 68, Issue:6 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost of Illness; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Costs; Female; Haloperidol; Health Care Costs; Hospitalization; Humans; Isoxazoles; Male; Middle Aged; Models, Econometric; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Sweden	2014
Alterations of the myristoylated, alanine-rich C kinase substrate (MARCKS) in prefrontal cortex in schizophrenia. Schizophrenia research, 2014, Volume: 154, Issue:1-3 Topics: Aged; Animals; Antipsychotic Agents; Blotting, Western; Down-Regulation; Female; Haloperidol; Humans; Intracellular Signaling Peptides and Proteins; Isomerism; Male; Membrane Proteins; Myristoylated Alanine-Rich C Kinase Substrate; Neoplasm Proteins; Phosphorylation; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Schizophrenia	2014
Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia. Schizophrenia research, 2015, Volume: 166, Issue:1-3 Topics: Aged; Animals; Antipsychotic Agents; Blotting, Western; Female; Gray Matter; Haloperidol; Humans; Male; N-Acetylglucosaminyltransferases; Prefrontal Cortex; Rats, Sprague-Dawley; Schizophrenia	2015
Multiple Long-Acting Injectable Antipsychotics for Treatment-Resistant Schizophrenia: Case Report. Journal of clinical psychopharmacology, 2016, Volume: 36, Issue:3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Drug Therapy, Combination; Haloperidol; Humans; Injections, Intramuscular; Male; Olanzapine; Schizophrenia	2016
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities. Schizophrenia research, 2010, Volume: 119, Issue:1-3 Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Length of Stay; Male; Microspheres; Middle Aged; Patient Discharge; Proportional Hazards Models; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2010
Case report: increased patient response to intramuscular haloperidol decanoate following a change in needle length. Journal of pharmacy practice, 2011, Volume: 24, Issue:6 Topics: Antipsychotic Agents; Biological Availability; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Injections, Intramuscular; Needles; Schizophrenia; Treatment Outcome; Young Adult	2011
Upregulation of cornichon transcripts in the dorsolateral prefrontal cortex in schizophrenia. Neuroreport, 2012, Dec-05, Volume: 23, Issue:17 Topics: Aged; Aged, 80 and over; Animals; Antipsychotic Agents; Egg Proteins; Female; Frontal Lobe; Gene Expression Regulation; Genetic Markers; Genetic Predisposition to Disease; Glutamic Acid; Haloperidol; Humans; Male; Membrane Proteins; Middle Aged; Nerve Tissue Proteins; Prefrontal Cortex; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptors, AMPA; RNA, Messenger; Schizophrenia; Synaptic Transmission; Up-Regulation	2012
[Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics]. L'Encephale, 2013, Volume: 39 Suppl 1 Topics: Adult; Antipsychotic Agents; Cross-Sectional Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Movement Disorders; Neurologic Examination; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Surveys and Questionnaires; Tunisia	2013
The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders. International journal of geriatric psychiatry, 2002, Volume: 17, Issue:11 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prodrugs; Psychotic Disorders; Schizophrenia	2002
Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2003, Jul-16, Volume: 23, Issue:15 Topics: Adult; Aged; Animals; Autoradiography; Benztropine; Calbindin 2; Cell Count; Female; gamma-Aminobutyric Acid; Gene Expression Profiling; Glutamate Decarboxylase; Haloperidol; Humans; In Situ Hybridization; Isoenzymes; Macaca fascicularis; Male; Middle Aged; Neural Inhibition; Neurons; Oligonucleotide Array Sequence Analysis; Parvalbumins; Prefrontal Cortex; RNA, Messenger; S100 Calcium Binding Protein G; Schizophrenia; Substrate Specificity; Synaptic Transmission; Time	2003
Long term results of unilateral posteroventral pallidotomy for antipsychotic drug induced tardive dyskinesia. Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:7 Topics: Athetosis; Chorea; Clopenthixol; Delayed-Action Preparations; Dominance, Cerebral; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Follow-Up Studies; Globus Pallidus; Haloperidol; Humans; Male; Middle Aged; Myoclonus; Neurologic Examination; Outcome Assessment, Health Care; Schizophrenia; Treatment Outcome	2005
Methodological issues in a study of long-term maintenance therapy with quetiapine versus haloperidol decanoate. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:3 Topics: Administration, Oral; Antipsychotic Agents; Dibenzothiazepines; Drug Administration Schedule; Haloperidol; Humans; Injections; Psychotic Disorders; Quetiapine Fumarate; Research Design; Sample Size; Schizophrenia; Treatment Outcome	2006
Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia. Psychiatric services (Washington, D.C.), 2007, Volume: 58, Issue:4 Topics: Administration, Oral; Adult; Alcoholism; Antipsychotic Agents; Black People; Cohort Studies; Comorbidity; Crime; Cross-Sectional Studies; Delayed-Action Preparations; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Illicit Drugs; Male; Middle Aged; Patient Readmission; Prospective Studies; Schizophrenia; Schizophrenia, Disorganized; Schizophrenic Psychology; Substance-Related Disorders; Treatment Outcome; United States; White People	2007
Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Middle Aged; Piperazines; Quinolones; Remission Induction; Schizophrenia; Substance-Related Disorders	2007
Haloperidol decanoate: a depot neuroleptic. Drug and therapeutics bulletin, 1983, May-20, Volume: 21, Issue:10 Topics: Antipsychotic Agents; Haloperidol; Humans; Kinetics; Schizophrenia	1983
[Long-term therapy of chronic schizophrenic patients with haloperidol decanoate]. Psychiatrische Praxis, 1984, Volume: 11, Issue:2 Topics: Adolescent; Adult; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Haloperidol; Humans; Long-Term Care; Male; Schizophrenia; Schizophrenic Psychology	1984
Intramuscular haloperidol decanoate for neuroleptic maintenance therapy. East African medical journal, 1984, Volume: 61, Issue:6 Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Delayed-Action Preparations; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Schizophrenia	1984
[Haloperidol decanoate. Results of an open-ended multicentric study in chronic psychotic states]. L'Encephale, 1984, Volume: 10, Issue:5 Topics: Adult; Delusions; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Psychotic Disorders; Schizophrenia	1984
The use of depot neuroleptic haloperidol decanoate. Acta psychiatrica Scandinavica, 1984, Volume: 69, Issue:2 Topics: Bipolar Disorder; Depressive Disorder; Haloperidol; Humans; Prognosis; Psychotic Disorders; Schizophrenia	1984
Pharmacokinetics of haloperidol decanoate. A 2-year follow-up. International pharmacopsychiatry, 1982, Volume: 17, Issue:4 Topics: Chronic Disease; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Kinetics; Male; Schizophrenia	1982
12-month study of haloperidol decanoate in chronic schizophrenic patients. International pharmacopsychiatry, 1982, Volume: 17, Issue:4 Topics: Adult; Aged; Chronic Disease; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology	1982
Clozapine in tardive Tourette syndrome. Biological psychiatry, 1995, Aug-01, Volume: 38, Issue:3 Topics: Adult; Antipsychotic Agents; Clozapine; Dyskinesia, Drug-Induced; Haloperidol; Humans; Injections, Intramuscular; Male; Neurologic Examination; Schizophrenia; Schizophrenic Psychology; Social Behavior; Substance Withdrawal Syndrome; Tourette Syndrome	1995
Seasonal variation in the dexamethasone suppression test: a longitudinal study in chronic schizophrenics and in healthy subjects. Neuropsychobiology, 1994, Volume: 30, Issue:2-3 Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dexamethasone; Female; Haloperidol; Humans; Hydrocortisone; Longitudinal Studies; Male; Melatonin; Middle Aged; Psychiatric Status Rating Scales; Radioimmunoassay; Reference Values; Schizophrenia; Schizophrenic Psychology; Seasons	1994
D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate. The American journal of psychiatry, 1995, Volume: 152, Issue:2 Topics: Adult; Ambulatory Care; Antipsychotic Agents; Basal Ganglia; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Schizophrenia; Tomography, Emission-Computed	1995
Do enzyme inducers modify haloperidol decanoate rate of release? Progress in neuro-psychopharmacology & biological psychiatry, 1994, Volume: 18, Issue:8 Topics: Antipsychotic Agents; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Humans; Phenobarbital; Schizophrenia	1994
Neuroleptic effects on serine and glycine metabolism. Biological psychiatry, 1993, Oct-15, Volume: 34, Issue:8 Topics: Adult; Animals; Antipsychotic Agents; Brain; Cytosol; Female; Fluphenazine; Glycine; Glycine Hydroxymethyltransferase; Haloperidol; Humans; Liver; Male; Mitochondria, Liver; Psychiatric Status Rating Scales; Rabbits; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Serine	1993
A loading-dose strategy for converting from oral to depot haloperidol. Hospital & community psychiatry, 1993, Volume: 44, Issue:12 Topics: Administration, Oral; Adult; Antipsychotic Agents; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Haloperidol; Humans; Injections, Intramuscular; Longitudinal Studies; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Retrospective Studies; Schizophrenia; Schizophrenic Psychology	1993
[Intraindividual comparison of haloperidol decanoate and oxyprothepine in maintenance therapy in schizophrenic psychoses]. Ceskoslovenska psychiatrie, 1993, Volume: 89, Issue:1 Topics: Adult; Antipsychotic Agents; Dibenzothiepins; Female; Haloperidol; Humans; Male; Schizophrenia	1993
Haloperidol decanoate (Janssen) in the treatment of schizophrenia. Ceskoslovenska psychiatrie, 1993, Volume: 89, Issue:1 Topics: Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Male; Schizophrenia	1993
EEG- and EP-mapping--possible indicators for disturbed information processing in schizophrenia? Progress in neuro-psychopharmacology & biological psychiatry, 1993, Volume: 17, Issue:4 Topics: Adult; Antipsychotic Agents; Brain Mapping; Electroencephalography; Evoked Potentials, Auditory; Haloperidol; Humans; Mental Processes; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	1993
3H-spiroperidol binding to peripheral mononuclear cells in schizophrenic and healthy subjects. Biological psychiatry, 1993, May-15, Volume: 33, Issue:10 Topics: Adult; Binding, Competitive; Clozapine; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Radioligand Assay; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology; Spiperone	1993
Reduced haloperidol/haloperidol ratios after oral haloperidol and decanoate administration in schizophrenics. Progress in neuro-psychopharmacology & biological psychiatry, 1993, Volume: 17, Issue:1 Topics: Administration, Oral; Adult; Chromatography, High Pressure Liquid; Female; Haloperidol; Humans; Male; Middle Aged; Regression Analysis; Schizophrenia	1993
Prolonged haloperidol and reduced haloperidol plasma concentrations after decanoate withdrawal. Schizophrenia research, 1993, Volume: 9, Issue:1 Topics: Adult; Female; Half-Life; Haloperidol; Humans; Injections, Intramuscular; Male; Metabolic Clearance Rate; Middle Aged; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome	1993
Effects of haloperidol decanoate on plasma homovanillic acid in chronic schizophrenic patients. Biological psychiatry, 1993, Apr-01, Volume: 33, Issue:7 Topics: Adult; Brain; Chronic Disease; Delayed-Action Preparations; Female; Haloperidol; Homovanillic Acid; Humans; Middle Aged; Schizophrenia; Schizophrenic Psychology	1993
Haloperidol and reduced haloperidol plasma concentrations after a loading dose regimen with haloperidol decanoate. Progress in neuro-psychopharmacology & biological psychiatry, 1996, Volume: 20, Issue:1 Topics: Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Male; Middle Aged; Schizophrenia	1996
Large variations of plasma levels during maintenance treatment with depot neuroleptics. The British journal of psychiatry : the journal of mental science, 1996, Volume: 169, Issue:5 Topics: Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Drug Monitoring; Female; Flupenthixol; Follow-Up Studies; Haloperidol; Humans; Injections, Intramuscular; Long-Term Care; Male; Middle Aged; Neurologic Examination; Perphenazine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	1996
Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine. Psychiatric services (Washington, D.C.), 1997, Volume: 48, Issue:1 Topics: Adult; Antipsychotic Agents; Chronic Disease; Cocaine; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Neurologic Examination; Opioid-Related Disorders; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Schizophrenia	1997
Delayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate. Preliminary findings. Archives of general psychiatry, 1997, Volume: 54, Issue:10 Topics: Adult; Antipsychotic Agents; Basal Ganglia; Brain; Delayed-Action Preparations; Dopamine Antagonists; Female; Haloperidol; Humans; Male; Mathematics; Middle Aged; Putamen; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Tomography, Emission-Computed	1997
Dopamine D2-receptor density in humans as assessed with SPET and the new high-affinity ligand 123I-NCQ298: a pilot study. Nuclear medicine communications, 1998, Volume: 19, Issue:3 Topics: Adult; Aged; Antipsychotic Agents; Brain; Cerebrovascular Circulation; Dopamine Agonists; Female; Haloperidol; Humans; Iodine Radioisotopes; Male; Middle Aged; Perphenazine; Pilot Projects; Radiopharmaceuticals; Receptors, Dopamine D2; Regional Blood Flow; Salicylamides; Schizophrenia; Tissue Distribution; Tomography, Emission-Computed, Single-Photon	1998
Rehospitalization rates for depot antipsychotics and pharmacoeconomic implications: comparison with risperidone. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Dec-15, Volume: 55, Issue:24 Suppl 4 Topics: Antipsychotic Agents; Baltimore; Chronic Disease; Delayed-Action Preparations; Disease-Free Survival; Female; Fluphenazine; Haloperidol; Humans; Length of Stay; Male; Patient Readmission; Risperidone; Schizophrenia; Time Factors	1998
Effects of smoking, CYP2D6 genotype, and concomitant drug intake on the steady state plasma concentrations of haloperidol and reduced haloperidol in schizophrenic inpatients. Therapeutic drug monitoring, 1999, Volume: 21, Issue:5 Topics: Adult; Aged; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Enzyme Induction; Enzyme Inhibitors; Genotype; Haloperidol; Humans; Inpatients; Middle Aged; Polymorphism, Genetic; Polypharmacy; Schizophrenia; Smoking	1999
Outcome comparison of patients receiving oral or depot neuroleptic medication. Psychological reports, 2001, Volume: 89, Issue:1 Topics: Administration, Oral; Adult; Antipsychotic Agents; Chronic Disease; Cohort Studies; Delayed-Action Preparations; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia	2001
EEG-brain mapping. A method to optimize therapy in schizophrenics using absolute power and center frequency values. Schizophrenia research, 1992, Volume: 8, Issue:1 Topics: Adult; Alpha Rhythm; Antipsychotic Agents; Brain Mapping; Cerebral Cortex; Dominance, Cerebral; Dose-Response Relationship, Drug; Drug Administration Schedule; Electroencephalography; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Signal Processing, Computer-Assisted	1992
Duration of neuroleptic treatment and relapse rate: a 5-year follow-up study with haloperidol decanoate. Clinical neuropharmacology, 1991, Volume: 14 Suppl 2 Topics: Antipsychotic Agents; Chronic Disease; Female; Follow-Up Studies; Haloperidol; Humans; Ireland; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology	1991
Effect of haloperidol decanoate on the cardiovascular system. The Japanese journal of psychiatry and neurology, 1991, Volume: 45, Issue:1 Topics: Adult; Antipsychotic Agents; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology	1991
Haloperidol decanoate in chronic schizophrenia: a study of 12 months with plasma levels. Progress in neuro-psychopharmacology & biological psychiatry, 1990, Volume: 14, Issue:1 Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Middle Aged; Recurrence; Schizophrenia	1990
Pharmacokinetic properties of haloperidol decanoate. Activitas nervosa superior, 1989, Volume: 31, Issue:1 Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Haloperidol; Humans; Schizophrenia	1989
Haloperidol decanoate in the treatment of schizophrenia. Activitas nervosa superior, 1989, Volume: 31, Issue:1 Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Schizophrenia	1989
Haloperidol decanoate. The Australian and New Zealand journal of psychiatry, 1989, Volume: 23, Issue:3 Topics: Adult; Bipolar Disorder; Female; Haloperidol; Humans; Patient Compliance; Schizophrenia; Schizophrenic Psychology	1989
Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations. Acta psychiatrica Scandinavica. Supplementum, 1985, Volume: 322 Topics: Administration, Oral; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Haloperidol; Humans; Kinetics; Long-Term Care; Patient Compliance; Perphenazine; Schizophrenia; Schizophrenic Psychology; Thiazines	1985
Advantages and disadvantages of depot-neuroleptics as maintenance medication for chronic schizophrenics. Clinical neuropharmacology, 1986, Volume: 9 Suppl 4 Topics: Administration, Oral; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Delayed-Action Preparations; Haloperidol; Humans; Maintenance; Schizophrenia	1986
Outcome of treatment with haloperidol decanoate in a patient with schizophrenia, chronic undifferentiated type, and end stage renal disease. Military medicine, 1988, Volume: 153, Issue:11 Topics: Adult; Antipsychotic Agents; Haloperidol; Humans; Kidney Failure, Chronic; Male; Schizophrenia	1988
Pharmacology, pharmacokinetics and clinical development of haloperidol decanoate. International clinical psychopharmacology, 1986, Volume: 1 Suppl 1 Topics: Animals; Delayed-Action Preparations; Dogs; Haloperidol; Humans; Schizophrenia	1986
The response of untreated chronic schizophrenics to haloperidol and haloperidol decanoate. International clinical psychopharmacology, 1986, Volume: 1 Suppl 1 Topics: Adult; Chronic Disease; Delayed-Action Preparations; Female; Haloperidol; Humans; Male; Schizophrenia	1986
Neuroendocrine effects of haloperidol decanoate in patients with chronic schizophrenia. Advances in biochemical psychopharmacology, 1985, Volume: 40 Topics: Adolescent; Adult; Chronic Disease; Drug Tolerance; Erectile Dysfunction; Female; Haloperidol; Humans; Male; Middle Aged; Prolactin; Schizophrenia; Sex Factors; Sexual Dysfunction, Physiological; Time Factors	1985